Polypill reduces cardiovascular events in heart attack patients compared to usual care
A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents further adverse cardiovascular events after a heart attack compared with taking the drugs…
Cardiovascular screening may reduce risk of death and cardiovascular disease
A randomised trial in more than 45,000 men has suggested that cardiovascular screening including cardiac imaging, blood pressure measurement and blood tests, plus treatment if needed, may lower…
Acetazolamide improves decongestion in patients with acute decompensated heart failure
Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients with acute decompensated heart failure, according to research presented at ESC Congress 2022.1
Coronary stenting does not benefit patients with severe left ventricular dysfunction
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalisation in patients with severe left ventricular dysfunction and extensive coronary artery disease, according research presented…
Meta-analysis strengthens evidence for SGLT2 inhibitors in patients with heart failure
An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and empagliflozin reduce cardiovascular death or hospitalisation for heart failure by 20% in heart…